According to the Zhitong Finance App, Shiyao Group (01093.HK) issued an announcement. Mesalazine enteric tablets (0.5g) (this product) developed by the Group have obtained a drug registration approval issued by the China Drug Administration and are deemed to have passed the consistent evaluation of the quality and efficacy of generic drugs.

According to the Zhitong Finance App, Shiyao Group (01093.HK) issued an announcement. Mesalazine enteric tablets (0.5g) (this product) developed by the Group have obtained a drug registration approval issued by the China Drug Administration and are deemed to have passed the consistent evaluation of the quality and efficacy of generic drugs.